BC Innovations | Oct 9, 2014
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Prostate apoptosis response-4 protein (PAR-4; PAWR) In vitro and mouse studies suggest the PAR-4 secretagogue arylquin 1 could help treat cancer. In coculture of...
BC Innovations | Aug 7, 2008
Targets & Mechanisms

PAR-4 Tees Off Lung Cancer

A paper in the EMBO Journal presents the first in vivo mechanistic evidence showing how a deficiency in prostate apoptosis response-4 protein contributes to Ras-induced non-small cell lung cancer. And it identifies the protein and...
BC Innovations | Jul 31, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker /pathway Summary Licensing status Publication and contact information Cancer Non-small cell lung cancer (NSCLC) Prostate apoptosis response protein 4 (Pawr; Par-4); Ras; protein kinase B (PKB; Akt); protein kinase...
Items per page:
1 - 3 of 3